Join Prognos Health on Wednesday, March 20, 2024 at 11:00am Eastern Time / 8:00am Pacific Time for a discussion with Ed Godber, Head of Life Sciences Data and Diagnostics at Guardant and Todd Somsel, Head of Real World Data Marketplace at Prognos Health,as we dive into the value of liquid biopsy data and how it can enhance HCP Alerts for better patient outcomes.
This session will equip you with valuable knowledge on:
- The growing adoption of liquid biopsies and their impact on patient diagnosis
- How life science companies can leverage liquid biopsy data to create more effective HCP engagement strategies
- Identifying scenarios where liquid biopsies offer a clearer picture than traditional tissue biopsies
If you are interested in attending please fill out the below form and we will send you a Zoom invitation.